|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 297.68 USD | +0.73% |
|
+2.51% | -15.63% |
| 07-14 | United Therapeutics Offers Favorable Profile Ahead of Key Data, Oppenheimer Says | MT |
| 06-30 | United Therapeutics' Tyvaso to Benefit from Q2 Seasonality, UBS Says | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.73% | +2.51% | +5.06% | +4.70% | -15.63% | -7.37% | +25.53% | +151.48% | +70.05% | 13.43B | ||
| +0.80% | +3.42% | -2.44% | +5.96% | +3.54% | -15.72% | +144.53% | +387.76% | +800.56% | 718B | ||
| -0.05% | +1.00% | -0.18% | +1.59% | +8.44% | +4.63% | -10.74% | +6.02% | +57.17% | 377B | ||
| -0.48% | +2.07% | +0.23% | +6.93% | +7.78% | +12.47% | +27.31% | +93.71% | +174.38% | 338B | ||
| -0.10% | -1.34% | -10.88% | +4.29% | -28.88% | -54.39% | +6.06% | +104.87% | +122.79% | 308B | ||
| -0.29% | -0.12% | -2.09% | +0.78% | +0.74% | -0.50% | -22.43% | -24.10% | -7.34% | 259B | ||
| +0.37% | -0.98% | +0.39% | +7.26% | +9.08% | -2.37% | +17.10% | +16.52% | -2.86% | 237B | ||
| -0.33% | +3.06% | -1.49% | +3.67% | +1.80% | -11.96% | -4.08% | +18.46% | +145.35% | 222B | ||
| +0.37% | +3.42% | +2.40% | +5.68% | -15.89% | -34.51% | -10.88% | +6.93% | +43.79% | 210B | ||
| +0.60% | +1.39% | +0.61% | +1.06% | +13.96% | -10.22% | +20.95% | +17.36% | +86.44% | 160B | ||
| -1.17% | +0.44% | +3.30% | +14.60% | -4.45% | -12.34% | -50.67% | -28.04% | -27.74% | 144B | ||
| +2.23% | +0.28% | +1.92% | +5.25% | +21.35% | +60.22% | +81.35% | +45.21% | -4.49% | 139B | ||
| +0.75% | +2.82% | +3.71% | -4.74% | +17.30% | -3.35% | +65.07% | +60.76% | +264.92% | 121B | ||
| -0.23% | +0.01% | -2.96% | -9.04% | -11.09% | -9.83% | -16.83% | -11.03% | -14.44% | 119B | ||
| +1.02% | +1.83% | -4.84% | -7.79% | -16.30% | +17.00% | -36.04% | -18.22% | -32.43% | 96.34B | ||
| +0.30% | +0.96% | -3.90% | +6.06% | +6.02% | -4.71% | -33.57% | -30.80% | -17.39% | 77.51B | ||
| -0.51% | -0.77% | -8.21% | +3.18% | -2.14% | +12.95% | +84.91% | +26.27% | +350.59% | 76.79B | ||
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | ||
| +0.54% | +8.66% | +6.16% | +17.07% | +24.64% | +38.62% | +48.48% | -30.25% | +303.10% | 53.34B | ||
| +1.93% | +1.18% | +2.51% | +6.85% | +6.31% | +4.83% | +11.43% | +19.39% | -28.46% | 46.68B | ||
| Average | +0.10% | +1.25% | -0.56% | +3.86% | +1.40% | -0.87% | +18.29% | +42.75% | +120.21% | 189.07B | |
| Weighted average by Cap. | -0.02% | +1.42% | -1.43% | +4.06% | +1.17% | -6.67% | +33.08% | +96.31% | +217.77% |
- Stock Market
- Equities
- UTHR Stock
- Sector United Therapeutics Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition